These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5598469)

  • 21. Combined study of serum proteins and lipoproteins by paper electrophoresis especially in hepatic and nephrotic syndromes and in atherosclerosis.
    NYS A
    Rev Belg Pathol Med Exp; 1954 Oct; 23(5):329-42. PubMed ID: 14372545
    [No Abstract]   [Full Text] [Related]  

  • 22. [Bile acids in coronary arteriosclerosis].
    Malaia LT; Shelest AN; Volkov VI; Cherevatov BG
    Kardiologiia; 1984 Oct; 24(10):81-4. PubMed ID: 6521190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipoprotein (a) as a risk factor in the development of atherosclerosis].
    Liakishev AA; Pokrovskiĭ SN; Susekov AV
    Kardiologiia; 1991 Feb; 31(2):71-5. PubMed ID: 1828281
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the composition of serum beta-lipoproteins in neurogenic and cholesterol-induced arteriosclerosis in rabbits].
    Podionova LP; Khomulo PS
    Kardiologiia; 1968 Oct; 8(10):46-52. PubMed ID: 5708804
    [No Abstract]   [Full Text] [Related]  

  • 25. [Action of some bile acids on the lipoprotein balance of serum].
    WAREMBOURG H; NIQUET G; LEKIEFFRE J
    Therapie; 1956; 11(6):1094-100. PubMed ID: 13409322
    [No Abstract]   [Full Text] [Related]  

  • 26. Gallstones, bile acids, and the liver.
    Lancet; 1989 Jul; 2(8657):249-51. PubMed ID: 2569056
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative serological study of the evolutive changes of biochemical and enzymatic components in humans and swine in relation to the pathogenesis of atherosclerosis].
    Albertini E; Belli C; Gori A; Pellegrini GF
    Arch Sci Med (Torino); 1967 Jan; 123(1):1-15. PubMed ID: 6057358
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cholesterol and atherosclerosis. The role of the bile acids in atherosclerosis].
    LIEBER II
    Sem Med; 1962 Jul; 121():233-40. PubMed ID: 13930526
    [No Abstract]   [Full Text] [Related]  

  • 29. Cholesterol and bile acid metabolism in middle-aged diabetics.
    Andersen E; Hellström P; Hellström K
    Diabete Metab; 1986 Oct; 12(5):261-7. PubMed ID: 3542619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chenodeoxycholic acid therapy for gallstones: effectiveness, toxicity and influence on bile acid metabolism.
    James O; Cullen J; Bouchier IA
    Q J Med; 1975 Apr; 44(174):349-67. PubMed ID: 1178813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of some lipido-protidic fractions ratio in atherosclerosis.
    Ciplea A; Baltă N; Căpâlnă S; Metz L; Drăgulescu N; Roşca M
    Rev Roum Physiol; 1971; 8(2):117-24. PubMed ID: 4125679
    [No Abstract]   [Full Text] [Related]  

  • 32. [Changes in metabolic parameters, especially in fat metabolism, in chronic alcoholics during clinical alcohol deficiency].
    Jaross W; Hanefeld M; Schentke KU; Trübsbach A; Stötzner H; Leonhardt W; Herrmann V; Fuchs R
    Z Gesamte Inn Med; 1972 Apr; 27(7):311-6. PubMed ID: 4114864
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cholesterol, lipoproteins and risk factors in atherosclerosis].
    Fruchart JC
    Rev Prat; 1986 Jan; 36(3):93-8. PubMed ID: 3945785
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of fasting and postprandial serum bile acid concentrations in hepatobiliary diseases].
    Cheng TC; Chen CF; Chou PT; Sheen TY
    Taiwan Yi Xue Hui Za Zhi; 1987 Apr; 86(4):413-21. PubMed ID: 3598551
    [No Abstract]   [Full Text] [Related]  

  • 35. [Humoral factors of circulatory disorders in chronic liver diseases].
    Ivkov VG
    Ter Arkh; 1975; 47(9):142-9. PubMed ID: 7023
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of calcium in the pathogenesis of gallstones: Ca++ electrode studies of model bile salt solutions and other biologic systems. With an hypothesis on structural requirements for Ca++ binding to proteins and bile acids.
    Moore EW
    Hepatology; 1984; 4(5 Suppl):228S-243S. PubMed ID: 6479882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Evaluation of the indicators of arteriosclerosis risk factors: cholesterol:HDL cholesterol and LDL cholesterol: HDL cholesterol in acute and chronic diseases of the liver].
    Simon K; Kowalewski W; Dobracki W
    Przegl Lek; 1987; 44(11):746-50. PubMed ID: 3447241
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of chenodeoxycholic acid (CDCA) on cholesterol absorption.
    Ponz de Leon M; Carulli N; Loria P; Iori R; Zironi F
    Gastroenterology; 1979 Aug; 77(2):223-30. PubMed ID: 447035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blood bile acids: metabolism, determinations and changes during hepatic diseases].
    Laulanie E; Pichot J; Nonnet L; Vachon A
    J Med Lyon; 1971 Dec; 52(219):1655-8 passim. PubMed ID: 5149542
    [No Abstract]   [Full Text] [Related]  

  • 40. [The value of estimating the blood serum cholesterol extraction factor in atherosclerosis].
    Anisimov VE
    Kardiologiia; 1966; 6(3):73-5. PubMed ID: 6001074
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.